What is the global market size of Infusion Pump Market?

Infusion Pump Market size was valued at USD 13.74 billion in 2021 and is poised to grow from USD 14.7 billion in 2022 to USD 27.03 billion by 2030, growing at a CAGR of 7% in the forecast period (2023-2030).

Who are the key vendors in the Global Infusion Pump Market?

The infusion pump market is characterised by the presence of well-established players as well as several small and medium-sized players. These manufacturers are pursuing a variety of strategies, including new product launches, product portfolio expansion, and mergers and acquisitions. Several large firms are forming multiple strategic alliances in order to increase their market share and get a competitive edge. 'Becton, Dickinson and Company (BD)', 'Baxter International Inc.', 'Fresenius Kabi AG', 'Terumo Corporation', 'ICU Medical, Inc.', 'Medtronic plc', 'Smiths Medical (a division of Smiths Group plc)', 'B. Braun Melsungen AG', 'Moog Inc.', 'Halyard Health, Inc.', 'Nipro Corporation', 'Johnson & Johnson', 'Roche Holding AG', 'Tandem Diabetes Care, Inc.', 'Insulet Corporation', 'Ypsomed AG', 'Valeritas Holdings, Inc.', 'Animas Corporation (a subsidiary of Johnson & Johnson)', 'Ambu A/S', 'Mindray Medical International Limited'.

What is the key driver of Global Infusion Pump Market?

The number of surgical procedures conducted around the world has increased significantly over the years. This can be ascribed to an ageing population as well as an increase in the prevalence of obesity and other lifestyle disorders. Obesity is a major cause of cardiovascular and orthopaedic illnesses. Obesity raises the risk of coronary heart disease, joint and tissue damage, cancer (of the breast, colon, prostate, endometrial, kidney, and gallbladder), ischemic stroke, and type 2 diabetes mellitus. Infusion pumps are essential for the continuous and regulated administration of medications during and after various types of surgery. Infusion pumps' primary application areas include chemotherapy, gastroenterology, analgesia/pain management, and diabetes.Following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy, infusion pumps are extensively utilised for the local delivery of narcotic analgesics and anaesthetics. The need for infusion therapy is predicted to rise as the number of procedures conducted rises.

What is the key market trend for Global Infusion Pump Market?

The rising frequency of chronic diseases, combined with the rising cost of hospital-based infusion therapy, has fuelled increased research and development efforts to provide home-based infusion solutions. For example, the expanding patient population in diabetes, cancer, and neurological illnesses has resulted in an increase in demand for long-term care, preferably at home. Furthermore, the expanding geriatric population in need of long-term care therapies is driving the development of new products aimed at home-based infusion therapies. The market's top companies are focusing on specialised medicine site of care management. Ivenix, Inc. created the Epic smart infusion pump in August 2020 to help patients avoid infusion-related injuries.

Which region accounted for the largest share in Global Infusion Pump Market?

Based on region, global infusion pump market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa. In 2020, the global infusion pump market in North America was valued at USD 3.52 billion. The regional market is characterised by greater diabetes diagnosis and treatment rates, as well as high adoption of ambulatory pumps and attractive reimbursement policies. The advancement of medical device technology in North America is boosting market growth. Europe has the second-largest market share. An increase in the frequency of chronic diseases in this region, as well as large European Commission expenditure in the healthcare sector, are expected to fuel demand for these pumps in Europe during 2021 –2028. The market in emerging regions such as Asia Pacific, Latin America, and the Middle East and Africa is expected to grow at a faster rate over the forecast period. Rise in the prevalence of chronic diseases such as diabetes and cancer, growing healthcare infrastructure, growing GDP, disposable income, and increasing awareness about the availability of advanced therapies in the Asia Pacific region are some of the factors expected to drive market growth in this region in the coming years. The market in Latin America, the Middle East, and Africa is still in its infancy. However, the increased focus of key players on expanding their presence in these countries will boost the market growth in these regions.

Infusion Pump Market Size, Share, Growth Analysis, By Product(Accessories And Consumables [Accessories and Consumables (Volumetric infusion pump dedicated disposables, Insulin pump dedicated disposables, Enteral infusion pump dedicated disposables, Syringe infusion pump dedicated disposables), By Setting(Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes), By Application(Chemotherapy/Oncology, Diabetes Management, Gastroenterology, Analgesia/Pain Management), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2184 | Region: Global | Published Date: September, 2024
Pages: 157 | Tables: 95 | Figures: 76

Infusion Pump Market Insights

Global Infusion Pump Market size was valued at USD 16.8 billion in 2022 and is poised to grow from USD 18.01 billion in 2023 to USD 31.41 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The infusion pump market is witnessing substantial growth owing to the launch of insulin pumps by major players in the industry such as Insulate Corporation and Medtronic. The major causes for this growth are the increasing prevalence of chronic diseases, advances in drug delivery technologies, and increasing adoption of these devices in emerging economies. This pump is one of the medical devices that administer the patient exactly the amount of fluid, nutrients, and drugs needed by the body. These are made specifically to perform unique functions, such as nutrition delivery through enteral feeding pumps, insulin administration through insulin pumps, and painkiller delivery through PCA pumps.

In addition, the healthcare sector is expected to expand its growth rate in the infusion pump market due to rising demand. The market is expected to grow with a rise in the rate of chronic disorders such as diabetes, cancer, and gastrointestinal disorders across the globe. This device is utilized in the medical sector to transfer accurately defined amounts of liquid into the body of a patient. It can often be used widely in hospitals and nursing homes for patients in a weak state of health. This is going to hike up the demand for infusion systems in the defense sector, and industrial expansion will follow suit.

US Infusion Pump Market is poised to grow at a sustainable CAGR for the next forecast year.

Infusion Pump Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The infusion pump industry is dominated by a good number of several significant players providing a wide variety of pump types in various application areas. Despite this being an extremely fragmented industry, companies such as Baxter, Medtronic, and Becton Dickinson can still hold market leadership within their product segment. The significant winning imperatives to be focused would include enlarging the product portfolio both organically and inorganically and strengthening the distribution networks globally, particularly in emerging countries such as China, Brazil, and India. Increased pressure on prices can help to force regional companies to bring their competition to this space. Other important players in this paper are B. Braun Melsungen AG and icumedical. 'Becton, Dickinson and Company (US) ', 'Baxter International Inc. (US) ', 'B. Braun Melsungen AG (Germany) ', 'Fresenius Kabi (Germany) ', 'Medtronic PLC (Ireland) ', 'Terumo Corporation (Japan) ', 'Nipro Corporation (Japan) ', 'Avanos Medical, Inc. (US) ', 'Insulet Corporation (US) ', 'Tandem Diabetes Care, Inc. (US) ', 'JMS Co., Ltd. (Japan) ', 'Roche Diagnostics (Switzerland) ', 'Moog, Inc. (US) ', 'Teleflex, Inc. (US) ', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) ', 'Ypsomed Holding AG (Switzerland) ', 'Micrel Medical Devices SA (Greece) ', 'Zyno Medical LLC (US) ', 'Infutronix (US) ', 'Epic Medical (US) ', 'Sooil Development Co., Ltd. (South Korea) ', 'Shenzhen Medrena Biotech Co., Ltd. (China) ', 'Codan Medizinische Gerate GmbH & Co. KG (Germany) ', 'Eitan Medical (Israel)'

The infusion pump market is highly influenced by the growing incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases. More and more patients require long-term care, and the devices become more crucial when there is the need for accuracy and reliability in drug delivery. The ability of infusion pumps to allow precise dosing and continuous infusions makes them indispensable in the management of complex treatment regimens. This trend is especially common in geriatric populations, which have many chronic conditions. The infusion pump industry is growing because healthcare providers are increasingly making use of advanced infusion technologies to increase safety, make procedures go faster, and advance patient care.

Home care is deeply affecting the infusion pump market. Patients prefer home over hospitals because of convenience and lower treatment cost. This change brings along a requirement for portable, patient-friendly infusion devices that could be used by patients or caregivers. They are concentrating their production lines on infusion pumps that can be used at the patient's home to try and cut down on congestion in hospitals and related costs. Manufacturers are now focusing more on infusion pumps that are designed for home use to enhance access and patient self-management of chronic diseases.

North America is a significant region in the infusion pump market due to several significant factors. Specialty infusion pumps are used highly in this region, especially for the control of chronic diseases, such as controlling diabetes and cancer. The demand is further necessitated by the increasingly aging population of North America, in which people spend most of their time requiring more intensive health care. The established health care sectors in the infusion pump market, focused on safety, make a distinction through advanced technologies, but sustained health care innovation expenditures are contributing to the growing U.S. market since they help ensure leadership in this crucial industry.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Infusion Pump Market Insights

Infusion Pump Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Infusion Pump Market?

Who are the key vendors in the Infusion Pump Market?

What is the key driver of Infusion Pump Market?

What is the key market trend for Infusion Pump Market?

Which region accounted for the largest share in Infusion Pump Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300